Ethan Rubinstein

Department of Medicine, Tel-Aviv University Sackler School of Medicine, Israel

Any competing interests declared are displayed with individual evaluations.

Section Head: Infectious Diseases > Antimicrobials & Drug Resistance (since 11 November 2005)

Ethan Rubinstein is a Section Head for Antimicrobials & Drug Resistance, part of the INFECTIOUS DISEASES Faculty. The role of a Section Head is to work with their Co-Section Head(s) to divide the Section (sub-specialty area) into its component areas of research, nominate leaders in those areas as Faculty Members, and offer ongoing oversight of the content within their Section. They are not asked to evaluate articles, although we do, of course, welcome them.

All recent recommendations

• 3.0
  Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
  Recommended by Ethan Rubinstein with Philippe Lagacé-Wiens
  
• 8.1
  Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.
  Recommended by Ethan Rubinstein with Phillipe Lagace-Wiens, Joseph John Jr, Brahm Segal with Iyer Parameswaren
  
• 3.0
  A 96-Week Comparison of Lopinavir-Ritonavir Combination Therapy Followed by Lopinavir-Ritonavir Monotherapy versus Efavirenz Combination Therapy.
  Recommended by Ethan Rubinstein with Philippe Lagacé-Wiens
  
• 3.0
  Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.
  Recommended by Ethan Rubinstein with Philippe Lagace-Wiens
  
• 3.0
  Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
  Recommended by Ethan Rubinstein with Phillipe Lagace-Wiens
  
• 3.0
  Effect of Reducing the Dose of Stavudine on Body Composition, Bone Density, and Markers of Mitochondrial Toxicity in HIV-Infected Subjects: A Randomized, Controlled Study
  Recommended by Ethan Rubinstein with P R S Lagacé-Wiens
  
• 3.0
  In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
  Recommended by Ethan Rubinstein with Philippe Lagacé-Wiens
  
• 4.8
  Telbivudine versus lamivudine in patients with chronic hepatitis B.
  Recommended by Ethan Rubinstein with Philippe Lagacé-Wiens, Ralf Weiskirchen with Frank Tacke
  
• 6.0
  Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.
  Recommended by Ethan Rubinstein